Bolloré Logistics Japan Certified CEIV Pharma by IATA At Narita And Haneda International Airport

posted on 28th November 2019 by Eddie Saunders
Bolloré Logistics Japan Certified CEIV Pharma by IATA At Narita And Haneda International Airport

On 31st October 2019, Bolloré Logistics Japan received the IATA CEIV Pharma certification for its logistics hub located in the Narita International Airport (NRT) and the Haneda International Airport (HND) in Tokyo. The last time Bolloré Logistics Japan received this globally recognized and standardized certification for its Healthcare air shipments was in March 2019, for its logistics hub located within the Kansai International Airport (KIX).

Bolloré Logistics Japan has begun the certification process according to the IATA CEIV Pharma standards since the second quarter of 2017. The CEIV Pharma certification will allow Bolloré Logistics Japan to have a strategic advantage in the Healthcare logistics market with a stronger, more competitive and enhanced air cargo service. 

“Pharmaceutical goods such as temperature-sensitive products are delicate and require careful handling during import and export globally and to domestic locations. Earning the CEIV Pharma certification at three of the main Japanese international airports in Osaka and Tokyo demonstrates our ability to successfully build and deploy a team of experts who are fully capable to offer end-to-end logistics solution for our Pharma customers,” said Goro UMEZAWA, Sales Manager at Bolloré Logistics Japan.

This new success, coupled with our continuous improvement to our processes and infrastructures to be compliant with IATA CEIV Pharma standards, shows our commitment to our pharma customers through achieving the highest standard in the global pharmaceutical supply chain. With Australia, Singapore, South Korea, China, and now Japan receiving the IATA CEIV certification, the aim of Bolloré Logistics is to deploy this action throughout its global network.

In Europe, Bolloré Logistics has already received the IATA CEIV Pharma certification for its Paris Roissy CDG platform in France, as well as its sites in Brussels (Belgium), Frankfurt (Germany) and Lisbon (Portugal).